(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.52%) $79.41
(1.19%) $1.955
(0.73%) $2 327.80
(0.19%) $26.80
(1.31%) $967.40
(0.03%) $0.933
(-0.02%) $11.03
(-0.06%) $0.798
(0.27%) $93.51
Live Chart Being Loaded With Signals
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally...
Stats | |
---|---|
आज की मात्रा | 975.00 |
औसत मात्रा | 332.00 |
बाजार मूल्य | 68.57B |
EPS | €0 ( 2024-02-12 ) |
अगली कमाई की तारीख | ( €0 ) 2024-05-22 |
Last Dividend | €0.375 ( 2023-07-20 ) |
Next Dividend | €0 ( N/A ) |
P/E | 31.63 |
ATR14 | €0 (0.00%) |
Zoetis Inc सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Zoetis Inc वित्तीय
Annual | 2023 |
राजस्व: | €8.54B |
सकल लाभ: | €5.98B (70.03 %) |
EPS: | €5.08 |
FY | 2023 |
राजस्व: | €8.54B |
सकल लाभ: | €5.98B (70.03 %) |
EPS: | €5.08 |
FY | 2022 |
राजस्व: | €8.08B |
सकल लाभ: | €5.63B (69.63 %) |
EPS: | €4.51 |
FY | 2021 |
राजस्व: | €7.78B |
सकल लाभ: | €5.47B (70.38 %) |
EPS: | €4.26 |
Financial Reports:
No articles found.
Zoetis Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0.325 (N/A) |
€0.325 (N/A) |
€0.375 (N/A) |
€0.375 (N/A) |
€0.375 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.200 | 2020-01-16 |
Last Dividend | €0.375 | 2023-07-20 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | €4.23 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.04 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.75 | |
Div. Directional Score | 7.96 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
MTE.DE | Ex Dividend Junior | 2023-07-07 | Quarterly | 0 | 0.00% | |
68V.DE | Ex Dividend Knight | 2023-08-07 | Quarterly | 0 | 0.00% | |
WAF.DE | Ex Dividend Junior | 2023-05-08 | Annually | 0 | 0.00% | |
FIE.DE | Ex Dividend Junior | 2023-07-14 | Annually | 0 | 0.00% | |
PAH3.DE | Ex Dividend Knight | 2023-07-03 | Annually | 0 | 0.00% | |
AP2.DE | Ex Dividend Knight | 2023-11-22 | Quarterly | 0 | 0.00% | |
HDI.DE | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
RWE.DE | Ex Dividend Junior | 2023-05-05 | Annually | 0 | 0.00% | |
CAR.DE | Ex Dividend Knight | 2023-06-06 | Annually | 0 | 0.00% | |
KEL.DE | Ex Dividend Knight | 2023-08-31 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.274 | 1.500 | 4.51 | 6.77 | [0 - 0.5] |
returnOnAssetsTTM | 0.164 | 1.200 | 4.53 | 5.44 | [0 - 0.3] |
returnOnEquityTTM | 0.488 | 1.500 | 5.68 | 8.53 | [0.1 - 1] |
payoutRatioTTM | 0.295 | -1.000 | 7.05 | -7.05 | [0 - 1] |
currentRatioTTM | 3.36 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.770 | 0.800 | 4.30 | 3.44 | [0.8 - 2.5] |
cashRatioTTM | 1.079 | 1.500 | 5.11 | 7.67 | [0.2 - 2] |
debtRatioTTM | 0.473 | -1.500 | 2.12 | -3.18 | [0 - 0.6] |
interestCoverageTTM | 13.61 | 1.000 | 6.07 | 6.07 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.11 | 2.00 | 8.30 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.52 | 2.00 | 8.24 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.352 | -1.500 | 4.59 | -6.89 | [0 - 2.5] |
grossProfitMarginTTM | 0.700 | 1.000 | 1.662 | 1.662 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.381 | 1.000 | 4.39 | 4.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.348 | 1.000 | 9.18 | 9.18 | [0.2 - 2] |
assetTurnoverTTM | 0.598 | 0.800 | 9.35 | 7.48 | [0.5 - 2] |
Total Score | 10.17 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 31.42 | 1.000 | 6.93 | 0 | [1 - 100] |
returnOnEquityTTM | 0.488 | 2.50 | 7.23 | 8.53 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.52 | 2.00 | 8.83 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.010 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.11 | 2.00 | 8.30 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.295 | 1.500 | 7.05 | -7.05 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.275 | 1.000 | 5.62 | 0 | [0.1 - 0.5] |
Total Score | 5.75 |
Zoetis Inc
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं